Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
2,623
Views
0
CrossRef citations to date
0
Altmetric
Pneumococcal – Research Paper

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial

Wenjuan Wanga Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Qi Lianga Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Jiahong Zhub Department of Acute Infectious Disease Control and Prevention, Lianshui County Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Junxia Zhangc Department of Acute Infectious Disease Control and Prevention, Huaiyin District Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Junsheng Chend Vice Director, Hongze District Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Sulan Xiee Administration Office, Hongze District Center for Disease Control and Prevention, Jiangsu, ChinaView further author information
,
Yuemei Hua Vaccine Clinical Evaluation Department, Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Guifan Lif Registration Department, Beijing Minhai Biotechnology Co., LTD., Beijing, ChinaView further author information
 show all
Article: 2019498 | Received 17 Sep 2021, Accepted 12 Dec 2021, Published online: 22 Feb 2022

References

  • GBD 2015 Mortality and Causes Of Death CollaboratorsWang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM et al . Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;385(9963):117–9. doi:10.1016/S0140-6736(14)61682-2.
  • Askim S, Mehl A, Paulsen J, DeWan AT, Vestrheim DF, Åsvold BO, Damås JK, Solligård E. Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993–2011: an observational study. BMC Infect Dis. 2016;16(1):1–9. doi:10.1186/s12879-016-1553-8.
  • Stockmann C, Ampofo K, Byington CL, Filloux F, Hersh AL, Blaschke AJ, Cowan P, Korgenski K, Mason EO, Pavia AT, et al. Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997–2010 in Utah. Pediatrics. 2013;132(3):421–28. doi:10.1542/peds.2013-0621.
  • Geno KA, Gilbert GL, Song JY, Skovsted IC, Klugman KP, Jones C, Konradsen HB, Nahm MH. Pneumococcal capsules and their types: past, present, and future. Clin Microbiol Rev. 2015;28(3):871–99. doi:10.1128/CMR.00024-15.
  • Eletu SD, Sheppard CL, Thomas E, Smith K, Daniel P, Litt DJ, Lim WS, Fry NK. Development of an extended-specificity multiplex immunoassay for detection of streptococcus pneumoniae serotype-specific antigen in urine by use of human monoclonal antibodies. Clin Vaccine Immunol. 2017;24:e00262–17. doi:10.1128/CVI.00262-17.
  • World Health Organization (WHO). Estimated Hib and pneumococcal deaths for children under 5 years of age, 2000, Mar 2014.
  • Chen C, Cervero Liceras F, Flasche S, Sidharta S, Yoong J, Sundaram N, Jit M. Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis. Lancet Glob Health. 2019;7(1):e58–67. doi:10.1016/S2214-109X(18)30422-4.
  • Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;3099:1–9. doi:10.1016/S1473-3099(15)70044-7.
  • Fu J, Yi R, Jiang Y, Xu S, Qin P, Liang Z, Chen J. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae causing invasive diseases in China: a meta-analysis. BMC Pediatr. 2019;19(1):424. doi:10.1186/s12887-019-1722-1.
  • Wernette CM, Frasch CE, Madore D, Carlone G, Nahm MH. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol. 2003;10:514–19. doi:10.1128/CDLI.10.4.514-519.2003.
  • Hu BT, Yu X, Jones TR, Kirch C, Harris S, Hildreth SW, Madore DV, Quataert SA. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae. Clin Diagn Lab Immunol. 2005;12(2):287–95. doi:10.1128/CDLI.12.2.287-295.2005.
  • Ruiz-Aragón J, Márquez Peláez S, Molina-Linde JM, Grande-Tejada AM. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis. Vaccine. 2013;31(46):5349–58. doi:10.1016/j.vaccine.2013.09.008.
  • Zhu F, Hu Y, Li J, Ye Q, Young MM, Liang JZ, Gruber WC, Giardina PC, Scott DA. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 versus 2 + 1 dose schedule among infants in China. Pediatr Infect Dis J. 2019;38(11):1150–58. doi:10.1097/INF.0000000000002458.
  • Zhu F, Hu Y, Liang Q, Young M, Zhou X, Chen Z, Liang JZ, Gruber WC, Scott DA. Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants. Ther Adv Drug Saf. 2015;6(6):206–11. doi:10.1177/2042098615613985.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.